These findings suggest that a small molecule PAI-1 inhibitor represents a novel class of anti-inflammatory agents targeting Mϕ migration by the inhibition of the interaction of PAI-1 with low-density lipoprotein receptor-related protein.
Ichimura, A., Matsumoto, S., Suzuki, S., Dan, T., Yamaki, S., Sato, Y., Kiyomoto, H., Ishii, N., Okada, K., Matsuo, O., Hou, F.-F., Vaughan, D. E., Van Ypersele de Strihou, C., & Miyata, T. (2013). A small molecule inhibitor to plasminogen activator inhibitor 1 inhibits macrophage migration. Arteriosclerosis, Thrombosis, and Vascular Biology, 33(5), 935-942. https://doi.org/10.1161/ATVBAHA.113.301224 (Original work published 2013)